DLD Asset Management »

Vir Biotechnology shares owned by DLD Asset Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $181k 30k 6.02

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Vir Biotechnology

BlackRock
Sb Investment Advisers
Arch Venture Corp
Vanguard Group
State Street Corporation
FMR
Dimensional Fund Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
Millennium Management
Standard Life Aberdeen
Hudson Bay Capital Management
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management

View all funds holding Vir Biotechnology